Related Experiment Video

Updated: May 25, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Modeling of miRNA and drug action in the EGFR signaling pathway

Jian Li1, Vikash Pandey, Thomas Kessler

  • 1Department Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. jianli@molgen.mpg.de

Plos One
|January 19, 2012
PubMed

Insights

MicroRNAs regulate key cellular processes. This study models the epidermal growth factor receptor (EGFR) pathway, revealing microRNA roles and potential new cancer drug targets.

Area of Science:

  • Molecular Biology
  • Systems Biology
  • Genomics

Background:

  • MicroRNAs (miRNAs) are crucial regulatory molecules involved in eukaryotic cell division, growth, development, and apoptosis.
  • The epidermal growth factor receptor (EGFR) signaling pathway is vital for cellular processes, and its dysregulation is linked to diseases like cancer.

Purpose of the Study:

  • To develop a systems biology model of the EGFR signaling pathway incorporating miRNA-target interactions.
  • To elucidate the essential roles of miRNAs within the EGFR signaling network.

Main Methods:

  • Construction of a comprehensive systems biology model of the EGFR pathway with 1241 reactions and 241 miRNAs.
  • Integration of validated miRNA-target information from diverse studies.
  • Analysis of the impact of 100 specific miRNA inhibitors (anti-miRNAs) on the pathway.

Main Results:

  • The developed model demonstrates the significant roles of miRNAs in regulating the EGFR signaling pathway.
  • Analysis revealed potential new drug targets within the miRNA-EGFR network.

Conclusions:

  • The integrated miRNA-network within the EGFR pathway model can identify novel therapeutic targets.
  • This approach supports the development of innovative therapeutic strategies for cancer treatment.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...